Related references
Note: Only part of the references are listed.Anaphylaxis: Revision of the Brighton collaboration case definition
Michael S. Gold et al.
VACCINE (2023)
Second dose of COVID-19 vaccination in immediate reactions to the first BNT162b2
Jaime S. Rosa Duque et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2022)
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Milena Sokolowska et al.
ALLERGY (2021)
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
Aleena Banerji et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Evaluating Rates and Determinants of COVID-19 Vaccine Hesitancy for Adults and Children in the Singapore Population: Strengthening Our Community's Resilience against Threats from Emerging Infections (SOCRATEs) Cohort
Konstadina Griva et al.
VACCINES (2021)
Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase
Catherine Mark et al.
PEDIATRIC BLOOD & CANCER (2021)
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
Matthew Greenhawt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
Anna R. Wolfson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Covid-19: People with history of significant allergic reactions should not receive Pfizer vaccine, says regulator
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Anaphylaxis:: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Jens U. Rueggeberg et al.
VACCINE (2007)